Search Within

Mark Kris

Formats
  1. Journal Article (478)
  2. Meeting Abstract (356)
  3. Conference Paper (16)
  4. Book Section (9)
  5. Review (6)
  6. Guidelines (2)
  7. Editorial (1)
  8. Miscellaneous (1)
  9. Research Letter (1)
Groups
  1. Department of Medicine (870)
  2. Solid Tumor Oncology Division (870)
  3. Thoracic Oncology (870)
  4. Department of Pathology and Laboratory Medicine (318)
  5. GSK Faculty (291)
  6. Human Oncology and Pathogenesis Program (224)

More Groups

People
  1. Gregory Riely (221)
  2. Marc Ladanyi (190)
  3. Vincent Miller (172)
  4. Valerie Rusch (130)
  5. Maria Arcila (123)
  6. Jamie Chaft (107)

More People

Years
  1. 2025 (5)
  2. 2024 (18)
  3. 2023 (27)
  4. 2022 (21)
  5. 2021 (21)
  6. 2020 (25)

More Years

Publications
  1. Journal of Clinical Oncology (235)
  2. Journal of Thoracic Oncology (131)
  3. Clinical Cancer Research (65)
  4. Cancer (33)
  5. Lung Cancer (31)
  6. Annals of Oncology (24)

More Publications

Publishers
  1. American Society of Clinical Oncology (253)
  2. Elsevier Inc. (179)
  3. American Association for Cancer Research (105)
  4. Oxford University Press (47)
  5. Wiley Blackwell (36)
  6. Elsevier Ireland Ltd. (30)

More Publishers

Results (870)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced non-small cell lung cancer
    Journal Article

    Rusch, V.; Klimstra, D.; Venkatraman, E.; Oliver, J.; Martini, N.; Gralla, R.; Kris, M.; Dmitrovsky, E.
    Cancer Research (1995)

    Fulltext@MSK | Save
  • Clinical and pharmacology study of chloroquinoxaline sulfonamide given on a weekly schedule
    Journal Article

    Rigas, J. R.; Francis, P. A.; Miller, V. A.; Tong, W. P.; Roistacher, N.; Kris, M. G.; Orazem, J. P.; Young, C. W.; Warrell, R. P. Jr
    Cancer Chemotherapy and Pharmacology (1995)

    Fulltext@MSK | Save
  • Oral combination antiemetics in patients with small cell lung cancer receiving cisplatin or cyclophosphamide plus doxorubicin
    Journal Article

    Cleri, L. B.; Kris, M. G.; Tyson, L. B.; Pisters, K. M. W.; Clark, R. A.; Gralla, R. J.
    Cancer (1995)

    Fulltext@MSK | Save
  • Phase II trial of a 75‐mg/m(2) dose of docetaxel with prednisone premedication for patients with advanced non‐small cell lung cancer
    Journal Article

    Miller, V. A.; Rigas, J. R.; Francis, P. A.; Grant, S. C.; Pisters, K. M. W.; Venkatraman, E. S.; Woolley, K.; Heelan, R. T.; Kris, M. G.
    Cancer (1995)

    Fulltext@MSK | Save
  • Ifosfamide plus high-dose cisplatin in patients with non-small cell lung cancer previously treated with chemotherapy
    Journal Article

    Miller, V. A.; Rigas, J. R.; Pisters, K. M. W.; Pfister, D. G.; Heelan, R. T.; Kris, M. G.
    American Journal of Clinical Oncology (1995)

    Fulltext@MSK | Save
  • Syndrome of acute dyspnea related to combined mitomycin plus vinca alkaloid chemotherapy
    Journal Article

    Rivera, M. P.; Kris, M. G.; Gralla, R. J.; White, D. A.
    American Journal of Clinical Oncology (1995)

    Fulltext@MSK | Save
  • Modulation of all-trans-retinoic acid pharmacokinetics by liarozole
    Meeting Abstract

    Miller, V. A.; Rigas, J. R.; Tong, W. P.; Kris, M. G.; Warrell, R. P. Jr
    Proceedings of the American Association for Cancer Research Annual Meeting (1994)

    Fulltext@MSK | Save
  • Strategies to control vomiting caused by anticancer drugs
    Conference Paper

    Kris, M. G.; Baltzer, L.; Hinkley, L.; Pisters, K. M. W.
    John Libbey & Co (1994)

    Fulltext@MSK | Save
  • Delayed emesis following anticancer chemotherapy
    Journal Article

    Kris, M. G.; Pisters, K. M. W.; Hinkley, L.
    Supportive Care in Cancer (1994)

    Fulltext@MSK | Save
  • Quality of life during clinical trials: Conceptual model for the Lung Cancer Symptom Scale (LCSS)
    Journal Article

    Hollen, P. J.; Gralla, R. J.; Kris, M. G.; Cox, C.
    Supportive Care in Cancer (1994)

    Fulltext@MSK | Save